Perioperative Immunotherapy - A KEY toward Improved Outcomes for Early-Stage Lung Cancer?

N Engl J Med. 2023 Aug 10;389(6):560-561. doi: 10.1056/NEJMe2305762.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Immunological* / administration & dosage
  • Antineoplastic Agents, Immunological* / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / surgery
  • Perioperative Period
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological